Skip to main content
    K

    Kairos Pharma, Ltd. (KAPA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $0.39
    -0.01 (-3.22%)

    Market Cap: $1.38M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Kairos Pharma, Ltd. (KAPA) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Kairos Pharma (KAPA) has a latest price of $0.39 on Nov 17, 2026. Its price fell 93.2% over the past 12 months.

    Price Chart

    From Sep 2024 to Oct 2026, its highest month-end close was $10.99 in Sep 2024 and its lowest $0.53 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart KAPA with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for KAPA.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 81.8%, and over 6 months it fell 88.2%.

    PeriodChange
    1 month-30.9%
    3 months-81.8%
    6 months-88.2%
    12 months-93.2%
    12 months, with dividends-93.2%
    Price change over each period. Dividends are not included unless the row says so.

    Price by Year

    YearCloseChange
    2026 through Oct 2026$0.53-89.3%
    2025$4.97-53.3%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 61.5% below its 50-day average of $1.02 and 85.7% below its 200-day average of $2.75.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.39
    50-day average$1.02-61.5%
    200-day average$2.75-85.7%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 97.8%.

    MeasureValue
    1-year beta1.57
    Largest fall, 1 year-94.2%
    Largest fall, 3 years-97.8%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About KAPA

    What is KAPA's 1-year price change?

    Kairos Pharma's price fell 93.2% over the past 12 months. With dividends included, the 12-month total return was -93.2%.

    What is KAPA's beta?

    Kairos Pharma's 1-year beta against the S&P 500 is 1.57, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 94.2%.

    Is the KAPA chart free?

    Yes. Advanced Charting for KAPA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.